Theodora Katsila,
Senior Research Scientist,
University of Patras
Dr. Katsila currently serves as a senior research fellow in the Pharmacogenomics and Personalized Medicine group in the University of Patras, Greece. She obtained her PhD in Chemistry from the University of Patras (Greece) and the Biomedical Research Foundation of the Academy of Athens (Greece). She holds a MSc in Clinical Biochemistry and Molecular Diagnostics (University of Athens, Greece) and a BSc in Biochemistry with a year in industry/research (Imperial College London, UK).
Dr. Katsila has acquired a multidisciplinary expertise, investigating the underlying molecular mechanisms of disease (cancer, inflammation) or focusing on drug research and development (Merck Sharp & Dohme Research Laboratories, UK) and more recently, biomarkers (cancer secretome) and personalized medicine (pharmacometabolomics-aided pharmacogenomics). She has developed substantial in vivo (rodents, primates) and in vitro skills (molecular and cell biology techniques, mass spectrometry approaches). Dr. Katsila was the VHIO’s (Vall d’ Hebron Institute of Oncology, Spain) lead scientist in the effort aimed at the modeling and predicting resistance to molecular therapies in colorectal cancer (COLTHERES). She is an EACR ambassador and an Associate of the Royal College of Science (UK).
|
|
Translating Pharmacogenomics into the Clinic: A Regulatory PerspectiveThursday, 8 October 2015 at 14:30 Add to Calendar ▼2015-10-08 13:59:002015-10-08 14:59:00Europe/LondonSession 4 – Future Developments in Personalized MedicinePersonalized Medicine and its Impact in the Clinic in Hanover, GermanyHanover, GermanySELECTBIOenquiries@selectbiosciences.comThe lecture will revolve around the regulatory issues and challenges to translate pharmacogenomics research findings into clinical applications to individualize drug treatment.
|